drugset / Trial / NCT07184632

A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or Obesity

NCT07184632

Phase 2 Active not recruiting 224 enrolled Novo Nordisk A/S
RandomizedSequentialQuadruple-blindTreatment

Summary

This study tests how well different doses of the medicine NNC0662-0419 help people living with overweight or obesity. The purpose of the study is to find out if NNC0662-0419 is safe and effective for treating people living with overweight or obesity. There are 2 study treatments in this study, participants will get either NNC0662-0419, the treatment being tested or placebo, a treatment that has no active medicine in it. NNC0662-0419 is a new medicine which cannot be pre-scribed by doctors but has previously been tested in humans.

Timeline

Start
2025-10-01
Primary completion
2026-12-14
Completion
2026-12-14

Drugs

EvaluationDrugModalityDoseRoute
Subject NNC0662-0419 Unknown Subcutaneous

Indications